Pfizer To Supply 6 Mln Paxlovid Treatment Courses To Fight Covid-19

Pfizer Inc. (PFE) said on Thursday that it will supply up to six million treatment courses of its Covid-19 oral treatment, Paxlovid, which includes Nirmatrelvir and Ritonavir tablets, to Global Fund as part of its Covid-19 Response Mechanism or C19RM.

The C19RM is focused on providing grant support to low- and middle-income countries to provide Covid-19 tests, treatments, personal protective equipment, and others.

Paxlovid treatment courses will be available for procurement by the 132 Global Fund-eligible low-and-middle-income countries starting in 2022.

The Global Fund is an agreement with UNICEF for the supply of up to four million treatment courses for low- and middle-income countries earlier this year.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Kraft Heinz Foods Co. is recalling around 2,400 pounds of ready-to-eat or RTE ham and cheese loaf products citing possible cross-contamination with under-processed products, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced. Foxconn, Apple Inc.'s key iPhone assembler, expects that its major plant in China, which is being hit hard by worker unrest following Covid-19 spread and related restrictions, would restart full production around late December to early January, Reuters reported citing a Foxconn source. Nestle Purina PetCare Co. has recalled a limited amount of certain prescription wet dog food citing labeling error, the U.S. Food and Drug Administration said. The recall involves Purina Pro Plan Veterinary Diets EN Gastroenteric Low Fat or PPVD EN Low Fat wet dog food that comes in 13.4 oz cans.
Follow RTT